Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
6.98
+0.23 (3.41%)
At close: Aug 13, 2025, 4:00 PM
6.95
-0.03 (-0.43%)
After-hours: Aug 13, 2025, 4:04 PM EDT
Contineum Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$22.50
Upside
+222.35%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +186.53% | May 19, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +344.13% | May 15, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +229.51% | Mar 13, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $25 | Buy | Initiates | $25 | +258.17% | Mar 7, 2025 |
| Baird | Baird | Buy Maintains $32 → $16 | Buy | Maintains | $32 → $16 | +129.23% | Mar 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +344.13% | Jan 9, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $32 → $31 | Buy | Maintains | $32 → $31 | +344.13% | Nov 7, 2024 |
| Baird | Baird | Buy Initiates $32 | Buy | Initiates | $32 | +358.45% | Oct 22, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $30 → $32 | Buy | Maintains | $30 → $32 | +358.45% | Aug 14, 2024 |
| Stifel | Stifel | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +315.47% | Apr 30, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $30 | Buy | Initiates | $30 | +329.80% | Apr 30, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $25 | Buy | Initiates | $25 | +258.17% | Apr 30, 2024 |